Statewide Drug Court Certification Toolkit: A Practical Guide to Establishing a Statewide Drug Court Certification Program

The Statewide Drug Court Certification Toolkit was created to offer guidance and assistance to states creating a drug court certification process. To achieve optimal outcomes, all drug courts should strive to follow the field’s best practices and maintain fidelity to the established drug court model. Drug courts that stray from this evidence-based approach risk harming […]

Strengthening the Foundation: A Look at Past, Present, and Future Research for Adult Drug Courts

As one component of the Strengthening the Foundation – A Researcher and Practitioner Partnership project funded by the Bureau of Justice Assistance, this research brief provides a snapshot of the existing evidence base behind the adult drug court model, while also identifying potential areas of interest to seed the next generation of drug court research. […]

Opioid Reduction Teleservices Program

When the COVID-19 pandemic hit New York in March 2020, it forced drug courts across the state to hear cases remotely using teleservices, a practice that has continued. The pandemic also demonstrated that many daily drug court operations—appearances, case management, graduation ceremonies—could be conducted virtually.  As part of the Bureau of Justice Assistance’s Comprehensive Opioid, […]

Veterans Treatment Court Strategic Planning

Innovative at their inception three decades ago, drug courts confront a practical and ethical obligation to reimagine some core practices and assumptions. A shifting legal and public health landscape means, for example, increased scrutiny of the courts’ focus on abstinence and mandated treatment, and the use of jail. Our publication argues the most effective way […]

TAKING ACTION: Treatment Courts and COVID-19

Due to COVID-19, the whole world was forced to be innovative in the ways we connect with one another. This document highlights some of the unique ways drug courts were able to stay engaged with clients throughout the pandemic. Some of these solutions have been so successful that the courts plan to integrate these practices […]

Medication for Opioid Use Disorder during COVID-19

In response to the intersecting risks of COVID-19 and the worsening overdose crisis, key regulations governing opioid agonist therapies have been loosened by the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Agency. These changes were needed as opioid users are at heightened risk for both COVID-19 infection and overdose for a […]